N'-hydroxy-5-(4-methylanilino)-3-oxo-1,2-thiazole-4-carboximidamide
C11H12N4O2S — CID 135988105
Data last refreshed: (MolForge compound catalog, from PubChem)
About N'-hydroxy-5-(4-methylanilino)-3-oxo-1,2-thiazole-4-carboximidamide
N'-hydroxy-5-(4-methylanilino)-3-oxo-1,2-thiazole-4-carboximidamide (PubChem CID 135988105) has the molecular formula C11H12N4O2S and a molecular weight of 264.31 g/mol. Its IUPAC name is N'-hydroxy-5-(4-methylanilino)-3-oxo-1,2-thiazole-4-carboximidamide.
Molecular Properties
| Compound Name | N'-hydroxy-5-(4-methylanilino)-3-oxo-1,2-thiazole-4-carboximidamide |
|---|---|
| PubChem CID | 135988105 |
| Molecular Formula | C11H12N4O2S |
| Molecular Weight | 264.31 g/mol |
| Exact Mass | 264.07 |
| IUPAC Name | N'-hydroxy-5-(4-methylanilino)-3-oxo-1,2-thiazole-4-carboximidamide |
| SMILES | Cc1ccc(Nc2s[nH]c(=O)c2/C(N)=N/O)cc1 |
| InChI | InChI=1S/C11H12N4O2S/c1-6-2-4-7(5-3-6)13-11-8(9(12)14-17)10(16)15-18-11/h2-5,13,17H,1H3,(H2,12,14)(H,15,16) |
| InChIKey | ABPNIXLAGUMYGJ-UHFFFAOYSA-N |
| XLogP | 1.58 |
| TPSA | 103.50 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 18 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 264.31 |
| LogP ≤ 5 | 1.58 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}, {'alert_name': 'oxime_1', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 135988105 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.